Axogen Company Leadership

AXGN Stock  USD 6.55  0.39  5.62%   
About 58% of Axogen's corporate insiders are selling. The analysis of insiders' sentiment of trading Axogen Inc stock suggests that many insiders are alarmed at this time. Axogen employs about 426 people. The company is managed by 37 executives with a total tenure of roughly 220 years, averaging almost 5.0 years of service per executive, having 11.51 employees per reported executive.
Karen Zaderej  CEO
CEO and President and Director
Jamie Grooms  Chairman
Co-Founder, Chairman, Member of Audit Committee and Member of Governance and Nominating Committee

Axogen's Insider Buying Vs Selling

42

 
Selling
 
Buying

Latest Trades

2024-03-21Michael Patrick DonovanDisposed 6033 @ 7.68View
2024-03-07Michael Patrick DonovanDisposed 36310 @ 8.81View
2023-12-11Peter J MarianiDisposed 12500 @ 7.5View
2023-09-06Amy Mcbride WendellAcquired 10000 @ 6.22View
2023-08-23William P Mr. BurkeAcquired 10000 @ 6.56View
2023-08-16Guido J NeelsAcquired 10000 @ 6.11View
2023-06-01Gregory Gene FreitagDisposed 41980 @ 8.71View
Monitoring Axogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Axogen's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Axogen's future performance. Based on our forecasts, it is anticipated that Axogen will maintain a workforce of about 430 employees by May 2024.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Axogen's latest congressional trading

Congressional trading in companies like Axogen Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Axogen by those in governmental positions are based on the same information available to the general public.
2019-06-24Representative Donna ShalalaDisposed Under $15KVerify

Axogen Management Team Effectiveness

The company has return on total asset (ROA) of (0.0684) % which means that it has lost $0.0684 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2208) %, meaning that it created substantial loss on money invested by shareholders. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of April 2024, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.12. At this time, Axogen's Debt To Assets are very stable compared to the past year. As of the 18th of April 2024, Asset Turnover is likely to grow to 0.95, though Non Currrent Assets Other are likely to grow to (83.2 M).
As of the 18th of April 2024, Common Stock Shares Outstanding is likely to grow to about 45 M, while Net Loss is likely to drop (27.4 M).

Axogen Workforce Comparison

Axogen Inc is rated below average in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 27,197. Axogen claims roughly 426 in number of employees contributing just under 2% to equities under Health Care industry.

Axogen Profit Margins

The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.460.8042
Way Down
Slightly volatile

Axogen Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Axogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-03-01
0.6071
17
28
 737,278 
 359,560 
2023-12-01
0.125
1
8
 65,476 
 20,836 
2023-06-01
0.7273
8
11
 67,504 
 91,952 
2023-03-01
1.0811
40
37
 1,159,669 
 347,782 
2022-12-01
1.2857
18
14
 134,031 
 124,494 
2022-09-01
0.7143
10
14
 184,452 
 256,508 
2022-06-01
3.2857
23
7
 190,580 
 34,455 
2022-03-01
1.3103
38
29
 1,574,765 
 121,653 
2021-12-01
0.5172
15
29
 82,250 
 92,812 
2021-09-01
0.7647
13
17
 202,027 
 187,177 
2021-06-01
1.6
32
20
 420,531 
 368,502 
2021-03-01
1.8182
40
22
 655,415 
 149,496 
2020-12-01
0.6667
20
30
 134,812 
 238,939 
2020-09-01
2.6667
8
3
 74,502 
 30,546 
2020-06-01
9.6667
29
3
 462,666 
 140,000 
2020-03-01
2.3529
40
17
 621,338 
 41,445 
2019-12-01
0.8889
8
9
 21,050 
 28,853 
2019-06-01
1.0
4
4
 70,922 
 126,008 
2019-03-01
1.5
9
6
 86,774 
 6,914 
2018-12-01
2.3636
26
11
 523,174 
 254,917 
2018-09-01
1.1429
8
7
 300,544 
 288,177 
2018-06-01
1.75
7
4
 50,900 
 37,682 
2018-03-01
0.2692
7
26
 140,650 
 464,357 
2017-12-01
1.4737
28
19
 391,596 
 2,600,928 
2017-09-01
0.5556
5
9
 175,150 
 80,618 
2017-06-01
3.5
7
2
 95,000 
 20,000 
2016-09-01
0.4286
3
7
 32,500 
 534,807 
2015-12-01
13.5
27
2
 752,250 
 17,263 
2015-09-01
0.7143
5
7
 229,000 
 424,659 
2015-06-01
8.0
8
1
 14,825 
 144,385 
2014-12-01
8.5
17
2
 318,500 
 50,000 
2014-06-01
9.5
19
2
 276,184 
 17,007 
2013-12-01
1.0
1
1
 290.00 
 290.00 
2013-03-01
2.6667
8
3
 138,296 
 6,796 
2012-06-01
1.0
2
2
 8,733 
 8,733 
2012-03-01
1.0
1
1
 1,500 
 15,019 
2011-12-01
8.4
42
5
 920,272 
 90,531 
2011-09-01
0.1111
1
9
 20,000 
 11,305 
2011-03-01
0.3333
2
6
 40,000 
 142,409 
2010-06-01
0.1111
1
9
 125,000 
 498,133 
2008-09-01
3.0
3
1
 98,000 
 3,727 
2004-03-01
2.0
2
1
 75,000 
 30,000 
2002-09-01
1.0
8
8
 213,000 
 213,000 

Axogen Notable Stakeholders

An Axogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Axogen often face trade-offs trying to please all of them. Axogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Axogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John EngelsCo-Founder and VPProfile
Karen ZaderejCEO and President and DirectorProfile
Jamie GroomsCo-Founder, Chairman, Member of Audit Committee and Member of Governance and Nominating CommitteeProfile
James GroomsIndependent Chairman of the BoardProfile
Mark FriedmanVice President - Regulatory and QualityProfile
Kevin LeachVice President - MarketingProfile
Kaila KrumVice President Investor Relations and Corporate DevelopmentProfile
Christopher CrismanVice President - U.S. SalesProfile
Angelo ScopelianosVice President - Research & DevelopmentProfile
Erick DeVinneyVice President of Clinical and Translational SciencesProfile
Gregory FreitagSenior Vice President - Business Development, General Counsel, DirectorProfile
Peter MarianiEx CFOProfile
Shawn McCarreySr. VP of SalesProfile
Joseph MandatoIndependent DirectorProfile
Mike DonovanDirector of OperationsProfile
Alan LevineDirectorProfile
Guido NeelsDirectorProfile
Quentin BlackfordDirectorProfile
Robert RudeliusIndependent DirectorProfile
Amy WendellDirectorProfile
Lisa ColleranDirectorProfile
Mark GoldIndependent DirectorProfile
Marc BeganGeneral VPProfile
Gregory DavaultVP MarketingProfile
CFA CPAChief OfficerProfile
Michael DonovanVice OperationsProfile
Doris QuackenbushVice SalesProfile
Harold TamayoVice RelationsProfile
Maria MartinezChief Human Resource OfficerProfile
Eric SandbergChief Commercial OfficerProfile
Isabelle BilletChief Strategy and Business Development OfficerProfile
Jens KempChief OfficerProfile
David HansenCorporate ControllerProfile
Bradley JDG OfficerProfile
Ed JoyceDirector RelationsProfile
Jon GingrichChief Commercial OfficerProfile
Ivica MDChief OfficerProfile

About Axogen Management Performance

The success or failure of an entity such as Axogen Inc often depends on how effective the management is. Axogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Axogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Axogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.11)(0.12)
Return On Capital Employed(0.13)(0.12)
Return On Assets(0.11)(0.12)
Return On Equity(0.23)(0.24)
The data published in Axogen's official financial statements usually reflect Axogen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Axogen Inc. For example, before you start analyzing numbers published by Axogen accountants, it's critical to develop an understanding of what Axogen's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Axogen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Axogen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Axogen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Axogen Inc. Please utilize our Beneish M Score to check the likelihood of Axogen's management manipulating its earnings.

Axogen Workforce Analysis

Traditionally, organizations such as Axogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Axogen within its industry.

Axogen Manpower Efficiency

Return on Axogen Manpower

Revenue Per Employee373.3K
Revenue Per Executive4.3M
Net Loss Per Employee51K
Net Loss Per Executive586.9K
Working Capital Per Employee135.2K
Working Capital Per Executive1.6M
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Axogen Stock analysis

When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Revenue Per Share
3.708
Quarterly Revenue Growth
0.187
Return On Assets
(0.07)
Return On Equity
(0.22)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.